LOS ANGELES, CA--(Marketwire - Jan 25, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), a leading provider of Personal Health Records ("PHR"), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, today announced that The MichaelBassGroup ("MBG"), a leading investment banking and strategic advisory services firm (www.michaelbass.com), issued a special report January 20, 2012 (http://michaelbass.com/PDF/JAN20MMRF.pdf) citing the global market for Personal Health Records at $19 billion, and focusing on the patents issued, pending and owned by MyMedicalRecords, Inc., the Company's wholly owned-subsidiary, in connection with a METHOD AND SYSTEM FOR PROVIDING ONLINE MEDICAL RECORDS, and a METHOD AND SYSTEM FOR PROVIDING ONLINE RECORDS. In their report, MBG valued these patents at a minimum of $300 million to as much as $800 million. The patents cover numerous claims involving the provision of Personal Health Records and other health information and document management systems and technologies. The patents (amongst other things) address the management of paper and other information contained in a Personal Health Record and deal with the fact that while doctors are migrating to Electronic Medical Records, they still receive an average of 1033 faxes per month of patient information.

According to the report, several movements are behind the growing popularity of PHRs, including social networking and the Health 2.0 movement. PHRs are also a tool for patient self-management on the Web. Many consumers have PHRs through their employers, health insurers, health providers or through independent vendors. One estimate indicates that 70 million people in the United States have access to a PHR.

The Company has already entered into a non-exclusive license agreement for $30 million with Surgery Center Management, LLC ("SCM"), $5 million of which became due on December 23, 2011. SCM purchased a cashier's check payable to MyMedicalRecords, Inc. as proof of funds, a copy of which has been given to the Company (see image). MMR has made demand on SCM to turn over the check and expects to bring a resolution to this matter through SCM Legal Counsel soon. Separately, the Company has also entered into a patent license agreement in Australia and other joint venture marketing and strategic partnership agreements in China.

The valuation was based on industry accepted patent evaluation methods, PatentValuePredictor.com, which was developed by Richard A. Neifeld and Dr. Martin Goffman. Dr. Neifeld holds a JD degree from George Washington University and a Ph.D. in Physics from Rutgers University and is the former chair of the Interference Committee of the American Intellectual Property Lawyers Association. Dr. Martin Goffman holds a Ph.D. in Chemistry from Temple University and is the principal of Martin Goffman Associates. Patent Value Predictor reports are based on patented macroeconomic models for automatically valuing patents. The reports are backed by patent and financial databases, which record the proprietary statistics used to predict the potential market size, and a patent's predicted share of this market. Many factors, such as the number of patents in the technology area, profit margins, and the GDP, figure into the statistically predicted valuation. The report specifically excludes the Company's biotech assets from the valuation.

The MBG Report concluded by stating: "Based on our analysis, the range of value for these patents could reach $300 to $800 million in revenue based on very conservative estimates that the market will reach the full GDP value of $19 billion."

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

About The MichaelBass Group

The MichaelBass Group (MBG) is an investment banking and strategic advisory services firm focused on healthcare information technology, healthcare IT services, healthcare mobility providers, medical technology and devices. MBG has been retained by the Company for investment banking services, valuations and M&A transactions. MBG Venture advisors work diligently with each client to ensure measurable results. Our team of research analysts conducts in depth analysis of the leading companies, trends, and helps our clients to identify transaction opportunities. The MichaelBass Group tracks and conducts research on over 400 emerging growth companies in the healthcare information technology sector. Our deep roots in healthcare include working with many public and private companies as well as industry associations and academic institutions. By combining technical expertise with invaluable industry insight in healthcare, The MichaelBass Group provides superior advisory services to every client engagement. www.michaelbass.com.

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue." MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to MMRGlobal, Inc.'s business prospects; results of operations or financial condition; valuation, guidance and projections provided by The MichaelBass Group; ability to establish and maintain beneficial relationships and strategic alliances; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; marketing and exploitation of our patent portfolio; uncertainties associated with doing business internationally across borders and territories; government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission.